Blog
RSS FeedPosted by Michael Wonder on 05 Sep 2018
Brad Hazzard’s call to stop free health care for tourists and visitors
6 September 2018 - All visitors to Australia will be required to have health insurance under a NSW government proposal ...
Posted by Michael Wonder on 05 Sep 2018
NICE u-turn approves funding for rare disease therapy Crysvita
5 September 2018 - NICE has changed its position on NHS funding for Kyowa Kirin International’s Crysvita, now endorsing the ...
Posted by Michael Wonder on 05 Sep 2018
Deal for NHS to offer exciting new child cancer therapy
5 September 2018 - A deal has been struck to let the NHS offer children an expensive new cancer therapy ...
Posted by Michael Wonder on 04 Sep 2018
Why aren't final base-case ICERs published in the PBAC Public Summary Documents?
5 September 2018 - The case for not doing so is now very weak. ...
Posted by Michael Wonder on 04 Sep 2018
Australian millennials are sick of paying for baby boomers' health care
5 September 2018 - Young people are quitting private health insurance in droves. ...
Posted by Michael Wonder on 04 Sep 2018
Merck gets partial thumbs-down on Keytruda in lymphoma from NICE cost-effectiveness watchdogs
4 September 2018 - NICE quibbled with Merck's methodology for demonstrating the cost effectiveness of Keytruda in treating Hodgkin lymphoma patients ...
Posted by Michael Wonder on 04 Sep 2018
Vertex announces reimbursement agreement in Australia for Orkambi (lumacaftor/ivacaftor) for people with cystic fibrosis ages six years and older with two copies of the F508del mutation
3 September 2018 - Approximately 1,300 patients in Australia join the thousands of patients worldwide who already have access to lumacaftor/ivacaftor. ...
Posted by Michael Wonder on 04 Sep 2018
Patient charges for PBS prescriptions: example calculations
4 September 2018 - Example calculations of patient charges for PBS prescriptions are now available. ...
Posted by Michael Wonder on 03 Sep 2018
Reducing the time from PBAC recommendation to PBS listing
4 September 2018 - Should other listing types be in the mix? ...
Posted by Michael Wonder on 03 Sep 2018
Biosimilar awareness initiative – literature review
3 September 2018 - The biosimilar literature review update for the period March 2018 to May 2018 is now available. ...
Posted by Michael Wonder on 03 Sep 2018
Medicare-funded cancer genetic tests: a note of caution
3 September 2018 - Clinicians need appropriate education and support in keeping pace with the genomics revolution. ...
Posted by Michael Wonder on 03 Sep 2018
Clark accused of cronyism over PHARMAC appointment
1 September 2018 - David Clark is faced with allegations of cronyism after appointing former Labour MP Steve Maharey chair ...
Posted by Michael Wonder on 03 Sep 2018
Patients wanting special funding for anti-depressants turned down by PHARMAC
2 September 2018 - Last year, PHARMAC stopped subsidising two brands of anti-depressants, Arrow Venlafaxine and Effexor XR, and replaced them ...
Posted by Michael Wonder on 03 Sep 2018
Agenda for September 5 TC meeting
3 September 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 02 Sep 2018
Eligible cystic fibrosis patients get free access to life-changing drug
2 September 2018 - More than 1200 Australians battling the incurable lung disease cystic fibrosis will be given immediate, free ...